Publications by authors named "Liliane S Pacheco"
The COVID-19 pandemic caused unprecedented pressure over health care systems worldwide. Hospital-level data that may influence the prognosis in COVID-19 patients still needs to be better investigated. Therefore, this study analyzed regional socioeconomic, hospital, and intensive care units (ICU) characteristics associated with in-hospital mortality in COVID-19 patients admitted to Brazilian institutions.
View Article and Find Full Text PDFPrevious studies that assessed risk factors for venous thromboembolism (VTE) in COVID-19 patients have shown inconsistent results. Our aim was to investigate VTE predictors by both logistic regression (LR) and machine learning (ML) approaches, due to their potential complementarity. This cohort study of a large Brazilian COVID-19 Registry included 4120 COVID-19 adult patients from 16 hospitals.
View Article and Find Full Text PDFA Retrospective Observational Cohort Study of Periprosthetic Hip Infection Treated by one-stage Method Including Cases With Bone Graft Reconstruction.
Clin Med Insights Arthritis Musculoskelet Disord
May 2022
Purpose: Prosthetic joint infection (PJI) is a devastating complication that can affect hip arthroplasty. Its treatment is extremely difficult, and issues regarding the optimal treatment remain unanswered. This study intended to show the effectiveness of the one-stage treatment of PJI.
View Article and Find Full Text PDFArticle Synopsis
- Many existing mortality risk scores for COVID-19 patients have high bias, prompting the need for a more reliable evaluation tool.
- A new prediction model was developed using data from nearly 4,000 COVID-19 patients, identifying seven key variables that indicate in-hospital mortality risk.
- This model showed strong accuracy in predicting outcomes and is accessible through an online calculator for healthcare professionals.*
Introduction: Many patients coinfected with the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are using highly active antiretroviral therapy (HAART) and HCV therapy with peginterferon (PEG-IFN) and ribavirina (RBV) because the use of direct-acting antivirals is not a reality in some countries. To know the impact of such medications in the sustained virological response (SVR) during HCV treatment is of great importance.
Methodology: This was a retrospective cohort study of 215 coinfected HIV/HCV patients.